Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Tissue Regenix
Life Sciences
Credit facilities expand cash runway to 2021
20 Jun 2019
Oxford BioMedica
Life Sciences
De-leveraging the balance sheet
18 Jun 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Allergy Therapeutics plc
Life Sciences
House dust mite vaccine – clinical progress
21 May 2019
Advanced Oncotherapy
Life Sciences
Commercialising a breakthrough technology
13 May 2019
Shield Therapeutics Plc
Life Sciences
All in the execution
13 May 2019
Advanced Oncotherapy
Life Sciences
Preparing for commercialisation
By
Dr Martin Hall
16 Apr 2019
ValiRx
Life Sciences
VAL401 is going forward
By
Dr Martin Hall
15 Apr 2019
Tissue Regenix
Life Sciences
Expanded GPO coverage secured
By
Dr Martin Hall
10 Apr 2019
Life Sciences
Global Pharmaceuticals: 2018 industry statistics
By
Dr Martin Hall
09 Apr 2019
genedrive Plc
Life Sciences
First commercial sales in new focus area: bio-threats
08 Apr 2019
Oxford BioMedica
Life Sciences
Deal-making drives first annual profit
02 Apr 2019
Prev
1
...
8
9
10
11
12
...
21
Next